April 22, 2021
The protein BRAT1 regulates how cells respond when their DNA is damaged, and it’s known to help drive cancer. But it’s also considered “undruggable” because it lacks binding sites that synthetic molecules need to be able to inhibit it.
How a novel drug from a medicinal shrub blocks a previously ‘undruggable’ breast cancer target
April 21, 2021
A cancer protein that was once considered “undruggable” has now become druggable thanks to a shrub that has successfully been synthesized.
Study credits shrub for making once ‘undruggable’ cancer protein treatable
April 21, 2021
A Purdue research team has used ITaP’s community clusters to model antibodies that neutralize enterovirus D68, a respiratory virus that sometimes causes a polio-like illness in children.
April 20, 2021
A chemist from Purdue University has found a way to synthesize a compound to fight a previously “undruggable” cancer protein with benefits across a myriad of cancer types.
‘Undruggable’ cancer protein becomes druggable, thanks to shrub
April 19, 2021
For thousands of years, humans have altered — often negatively and inadvertently — microbial communities in a quest to improve agricultural crops.
Purdue team predicts next-generation microbiome research promises agricultural advances
April 17, 2021
With the Johnson & Johnson COVID-19 vaccine still on pause in the U.S. after reports of a rare but severe blood clotting disorder in a small number of the roughly 7 million people who've received the shot, health experts now are focusing on what could be behind those uncommon adverse events.
Scientists exploring possible link between Johnson & Johnson, AstraZeneca vaccine blood clot issues
April 16, 2021
The 2021 PVM Research Day included the inaugural presentation of a new award designed to recognize faculty mentors. The Purdue Veterinary Research Scholars Summer Program provides an opportunity for DVM students and pre-vet undergraduate students to gain research experience under guidance of a faculty mentor. The success of the program depends greatly on the involvement and effort of the mentors. The Boehringer Ingelheim Summer Research Mentorship Award was established to recognize a faculty mentor who has demonstrated a special effort.
New Boehringer Ingelheim Summer Research Mentorship Award Presented
April 15, 2021
Purdue University is offering a new online course in evaluating bone marrow for veterinary pathologists practicing in academia, the pharmaceutical industry and diagnostic positions, as well as clinical and anatomic pathologists in training.
April 13, 2021
Purdue researchers working with an international team of scientists have discovered that a hyperactive immune response in lung cells is likely behind some of the most severe COVID-19 cases.
Drug Combination Could Treat Severe Covid Cases, Purdue Research Finds
April 13, 2021
Technology to provide new options for patients with neurological disease and pain has received major new support. Neuro Vigor, a Purdue University-affiliated startup, won a $100,000 Early Commercialization Award from the Indiana Spinal Cord and Brain Injury Research Fund. The company’s proprietary drugs offer new disease-modifying therapies to reduce patient suffering in neuro-degenerative conditions. This is the first time the research fund has provided support to an early commercialization company.
Technology to treat neurological diseases, pain wins Indiana fund’s commercialization award
